Amylyx Pharmaceuticals (NASDAQ:AMLX) CFO Sells $154,674.70 in Stock
MarketBeat
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) CFO James Frates sold 10,558 shares of the company's stock in a transaction that occurred on Tuesday, September 30th. The shares were sold at an average price of $14.65, for a total value of $154,674.70. Following the completion of the transaction, the chief financial officer directly owned 280,430 shares of the company's stock, valued at approximately $4,108,299.50. This trade represents a 3.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
NASDAQ:AMLX